Active Ingredient(s): Thiotepa
FDA Approved: * January 26, 2017
Pharm Company: * ADIENNE SA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tepadina Overview

ThioTEPA or thiotepa (INN,[1] chemical name: N,N′,N″-triethylenethiophosphoramide) is an alkylating agent used to treat cancer. ThioTEPA is an organophosphorus compound with the formula SP(NC2H4)3.[2] It is an analogue of N,N′,N″-triethylenephosphoramide (TEPA). This molecule features tetrahedral phosphorus and is structurally akin to phosphate. It is manufactured by heating aziridine with thiophosphoryl chloride. History and Use ThioTEPA was first developed by the A...

Read more Tepadina Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/ThioTEPA

Recent Tepadina Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 15mg, 15mg/vial, 30mg, 30mg/vial
  • Powder: 100mg/vial, 15mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tepadina: (2 results)

Sorted by National Drug Code
  • 53964-001 Tepadina 15 mg/1 Intravenous Injection, Powder, for Solution by Adienne Sa
  • 53964-002 Tepadina 100 mg/1 Intravenous Injection, Powder, for Solution by Adienne Sa

Other drugs which contain Thiotepa or a similar ingredient: (2 results)